In Vitro & In Vivo Diagnostic Substances Industry - SEC Form 4 Insider Trading Screener

Manufacturing Sector - Chemicals - In Vitro & In Vivo Diagnostic Substances
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
100 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Company

Insider Name

Insider Title

Trade Type 

Share Price

Shares Traded

Shares Owned

Own chg

Value Traded

1d ret

1w ret

1m ret

6m ret

D
2018-07-12
QDELQuidel Corp /de/Russell Edward KeithS.VP, N.A. Commercial OpsS - Sale+OE$68.09-10,0008,887-53%-$680,938
DM
2018-06-27
QDELQuidel Corp /de/Bryant Douglas CPres, CEOS - Sale+OE$66.05-36,000294,313-11%-$2,377,644
2018-06-25
LNTHLantheus Holdings, Inc.McHugh JulieDirS - Sale$14.72-4,56014,752-24%-$67,123
2018-06-19
NTLAIntellia Therapeutics, Inc.Formela Jean FrancoisDirS - Sale$27.96-6,6861,836,8100%-$186,908
D
2018-06-18
MYGNMyriad Genetics IncLanchbury Jerry SChief Scientific OfficerS - Sale+OE$40.12-60,000138,809-30%-$2,407,200
D
2018-06-18
MYGNMyriad Genetics IncMarsh Richard ME.VP, GCS - Sale+OE$40.00-33,000124,197-21%-$1,320,000
2018-06-15
IMMUImmunomedics IncVenbio Select Advisor LLCSee Remarks, 10%P - Purchase$23.39+200,00017,714,461+1%+$4,678,000
2018-06-15
CLDXCelldex Therapeutics, Inc.Keler TiborEVP, CSOP - Purchase$0.59+16,50035,368+87%+$9,783
2018-06-15
IMMUImmunomedics IncVenbio Select Advisor LLCSee Remarks, 10%P - Purchase$24.00+575,00017,514,461+3%+$13,800,000
2018-06-12
QDELQuidel Corp /de/Kroll WernerSVP, R, DS - Sale$66.16-2,50016,005-14%-$165,392
DM
2018-06-11
QDELQuidel Corp /de/Borkar Ratan SSVP, Intl Comm OperationsS - Sale+OE$65.00-26,55513,134-67%-$1,726,075
DM
2018-06-06
MYGNMyriad Genetics IncLanger DennisDirS - Sale+OE$39.35-20,36939,743-34%-$801,594
DM
2018-06-05
MYGNMyriad Genetics IncGilbert Walter PhdDirS - Sale+OE$39.69-30,00027,243-52%-$1,190,589
DM
2018-06-01
MYGNMyriad Genetics IncLanger DennisDirS - Sale+OE$39.30-49,63139,743-56%-$1,950,277
D
2018-05-30
MYGNMyriad Genetics IncCapone Mark ChristopherPres, C.E.O.S - Sale+OE$38.00-90,000332,175-21%-$3,420,000
D
2018-05-30
MYGNMyriad Genetics IncMarsh Richard ME.VP, GCS - Sale+OE$38.00-33,139123,769-21%-$1,259,282
D
2018-05-30
MYGNMyriad Genetics IncLanger DennisDirS - Sale+OE$37.92-10,00039,743-20%-$379,245
DM
2018-05-29
QDELQuidel Corp /de/Bryant Douglas CPres, CEOS - Sale+OE$62.08-36,000294,313-11%-$2,234,700
D
2018-05-30
IDXXIdexx Laboratories Inc /deStuder JacquelineCVP, Gen. Counsel, SecretaryS - Sale+OE$209.98-4755,825-8%-$99,741
2018-05-29
IDXXIdexx Laboratories Inc /deTwigge GiovaniCORPORATE VPS - Sale$204.37-1,62614,150-10%-$332,306
D
2018-05-25
QDELQuidel Corp /de/Brown Thomas DDirS - Sale+OE$61.34-30,45153,958-36%-$1,867,864
M
2018-05-22
QTNTQuotient LtdPerceptive Advisors LLC10%P - Purchase$6.45+450,0006,483,020+7%+$2,903,117
D
2018-05-21
MYGNMyriad Genetics IncLanger DennisDirS - Sale+OE$35.90-10,00039,743-20%-$359,000
2018-05-16
NEOGNeogen CorpPapesh G BruceDirS - Sale$72.50-6,00026,261-19%-$435,000
2018-05-16
NTLAIntellia Therapeutics, Inc.Formela Jean FrancoisDirS - Sale$25.04-6,6862,058,2990%-$167,389
2018-05-14
NTLAIntellia Therapeutics, Inc.Leonard John M.Pres, CEOS - Sale$24.00-8,400525,767-2%-$201,600
2018-05-10
IDXXIdexx Laboratories Inc /deEnd William TDirS - Sale$208.36-9,47031,786-23%-$1,973,163
M
2018-05-08
NEOGNeogen CorpHerbert James LExec COBS - Sale$71.50-36,000166,812-18%-$2,574,078
D
2018-05-07
NEOGNeogen CorpQuinlan Steven J.CFOS - Sale+OE$71.82-5,00013,470-27%-$359,092
2018-05-01
LNTHLantheus Holdings, Inc.Orlandi CesareChief Medical OfficerS - Sale$18.04-4,51090,806-5%-$81,370
D
2018-05-01
OXFDOxford Immunotec Global PlcSandberg Richard ADirS - Sale+OE$12.77-3,00015,000-17%-$38,304
M
2018-04-27
LNTHLantheus Holdings, Inc.Orlandi CesareChief Medical OfficerS - Sale$18.00-8,80195,316-8%-$158,457
DM
2018-04-26
QDELQuidel Corp /de/Bryant Douglas CPres, CEOS - Sale+OE$56.09-36,000294,313-11%-$2,019,168
2018-04-26
LNTHLantheus Holdings, Inc.Orlandi CesareChief Medical OfficerS - Sale$18.00-4,194104,117-4%-$75,492
2018-04-18
NEOGNeogen CorpBoehm William TDirS - Sale$69.84-50010,480-5%-$34,920
D
2018-04-17
VRMLVermillion, Inc.Schuler Henri George10%P - Purchase$1.00+2,107,7749,262,363+29%+$2,107,774
D
2018-04-17
VRMLVermillion, Inc.Schuler Jack W10%P - Purchase$1.00+2,838,09013,416,342+27%+$2,838,090
2018-04-16
NEOGNeogen CorpHerbert James LExec COBS - Sale$68.50-20,0001,508,361-1%-$1,370,000
D
2018-04-10
NEOGNeogen CorpBoehm William TDirS - Sale+OE$67.94-1,0208,980-10%-$69,300
D
2018-04-06
NEOGNeogen CorpMorrical Terri AVPS - Sale+OE$67.78-14,80037,575-28%-$1,003,206
D
2018-04-03
LNTHLantheus Holdings, Inc.Duffy Michael PSee RemarksS - Sale+OE$15.30-27,313164,159-14%-$417,897
2018-04-03
ABIOArca Biopharma, Inc.Keuer Thomas ACOOS - Sale$0.50-48213,153-4%-$242
2018-04-02
ABIOArca Biopharma, Inc.Selby Brian L.VP, FinanceS - Sale$0.50-1,1140-100%-$556
2018-03-28
OCXOncocyte CorpBroadwood Partners, L.P.10%P - Purchase$1.26+3,968,25415,133,013+36%+$5,000,000
DM
2018-03-27
QDELQuidel Corp /de/Bryant Douglas CPres, CEOS - Sale+OE$51.63-36,000294,313-11%-$1,858,740
D
2018-03-27
NEOGNeogen CorpQuinlan Steven J.VP, CFOS - Sale+OE$66.13-5,00013,470-27%-$330,648
D
2018-03-26
NEOGNeogen CorpQuinlan Steven J.VP, CFOS - Sale+OE$64.97-2,86613,470-18%-$186,213
2018-03-26
NYMXNymox Pharmaceutical CorpRobinson James GeorgeDirP - Purchase$3.93+8,0003,160,5500%+$31,434
D
2018-03-23
NEOGNeogen CorpReed Thomas HDirS - Sale+OE$62.47-6,00013,375-31%-$374,818
2018-03-20
NYMXNymox Pharmaceutical CorpRobinson James GeorgeDirP - Purchase$4.02+8,0003,152,5500%+$32,160
2018-03-20
NTLAIntellia Therapeutics, Inc.Formela Jean FrancoisDirS - Sale$23.87-39,2452,279,788-2%-$936,743
2018-03-14
LNTHLantheus Holdings, Inc.Duffy Michael PSee RemarksS - Sale$16.60-11,492164,159-7%-$190,775
2018-03-15
NYMXNymox Pharmaceutical CorpRobinson James GeorgeDirP - Purchase$3.58+8,0003,144,5500%+$28,672
M
2018-03-07
IMMUImmunomedics IncGoldenberg David MDirS - Sale$17.41-117,7297,387,537-2%-$2,049,389
2018-03-09
NYMXNymox Pharmaceutical CorpRobinson James GeorgeDirP - Purchase$3.48+8,0003,136,5500%+$27,864
D
2018-02-28
IDXXIdexx Laboratories Inc /deJunius Daniel MDirS - Sale+OE$190.06-2,9742,628-53%-$565,232
2018-02-28
ABIOArca Biopharma, Inc.Keuer Thomas ACOOS - Sale$0.72-41013,635-3%-$294
2018-02-27
ABIOArca Biopharma, Inc.Selby Brian L.VP, FinanceS - Sale$0.53-1611,114-13%-$85
DM
2018-02-26
QDELQuidel Corp /de/Bryant Douglas CPres, CEOS - Sale+OE$44.32-36,000290,843-11%-$1,595,520
M
2018-02-26
ABIOArca Biopharma, Inc.Venrock Healthcare Capital Partners LP10%S - Sale$0.55-1,541,3310-100%-$846,905
2018-02-26
LNTHLantheus Holdings, Inc.Healey Timothy GSVP, CommercialS - Sale$19.58-3,69660,886-6%-$72,358
2018-02-26
ABIOArca Biopharma, Inc.Sonsini Peter W.10%S - Sale$0.50-1,460,2090-100%-$731,273
2018-02-26
ABIOArca Biopharma, Inc.Sandell Scott D10%S - Sale$0.50-1,460,2090-100%-$731,273
2018-02-26
ABIOArca Biopharma, Inc.Sakoda Jon10%S - Sale$0.50-1,460,2090-100%-$731,273
2018-02-26
ABIOArca Biopharma, Inc.Mott David M10%S - Sale$0.50-1,460,2090-100%-$731,273
2018-02-26
ABIOArca Biopharma, Inc.Makower Joshua10%S - Sale$0.50-1,460,2090-100%-$731,273
2018-02-26
ABIOArca Biopharma, Inc.Florence Anthony A. Jr.10%S - Sale$0.50-1,460,2090-100%-$731,273
2018-02-26
ABIOArca Biopharma, Inc.Baskett Forest10%S - Sale$0.50-1,460,2090-100%-$731,273
2018-02-26
ABIOArca Biopharma, Inc.Barris Peter J10%S - Sale$0.50-1,460,2090-100%-$731,273
2018-02-26
ABIOArca Biopharma, Inc.Growth Equity Opportunities Iv, LLC10%S - Sale$0.50-1,460,2090-100%-$731,273
2018-02-23
VIVOMeridian Bioscience IncMcIlwraith JohnDirP - Purchase$14.03+1,0004,000+33%+$14,034
2018-02-22
IDXXIdexx Laboratories Inc /deEnd William TDirS - Sale$184.49-4,00041,256-9%-$737,939
2018-02-21
NYMXNymox Pharmaceutical CorpRobinson James GeorgeDirP - Purchase$3.23+6,0003,128,5500%+$19,373
D
2018-02-21
NEOGNeogen CorpQuinlan Steven J.VP, CFOS - Sale+OE$60.15-2,00013,470-13%-$120,294
DM
2018-02-20
NEOGNeogen CorpHerbert James LExec COBS - Sale+OE$59.32-25,3341,150,926-2%-$1,502,879
D
2018-02-21
QTNTQuotient LtdVon Prondzynski HeinoDirP - Purchase$4.28+12,00073,229+20%+$51,348
M
2018-02-16
NEOGNeogen CorpBradley EdwardVP (Retired)S - Sale$59.60-7,0009,958-41%-$417,223
2018-02-16
NYMXNymox Pharmaceutical CorpRobinson James GeorgeDirP - Purchase$3.27+7,0003,122,5500%+$22,921
2018-02-15
NEOGNeogen CorpHerbert James LExec COBS - Sale$57.50-10,0001,528,361-1%-$574,954
2018-02-14
IDXXIdexx Laboratories Inc /deKingsley Lawrence DDirP - Purchase$178.04+1,0004,558+28%+$178,045
DM
2018-02-15
OXFDOxford Immunotec Global PlcSandberg Richard ADirS - Sale+OE$12.01-3,00015,000-17%-$36,038
2018-02-12
NYMXNymox Pharmaceutical CorpRobinson James GeorgeDirP - Purchase$3.27+8,0003,115,5500%+$26,161
D
2018-02-08
QTNTQuotient LtdMcDonough BrianDirP - Purchase$3.87+10,00047,747+26%+$38,680
2018-02-09
NYMXNymox Pharmaceutical CorpRobinson James GeorgeDirP - Purchase$3.18+7,0003,107,5500%+$22,254
2018-02-07
IDXXIdexx Laboratories Inc /deClaflin Bruce L.DirP - Purchase$179.58+1,0001,000New+$179,580
DM
2018-02-07
IDXXIdexx Laboratories Inc /deAyers Jonathan WCOB, Pres, CEOS - Sale+OE$177.52-22,0001,157,112-2%-$3,905,383
2018-02-08
NYMXNymox Pharmaceutical CorpRobinson James GeorgeDirP - Purchase$3.37+10,0003,100,5500%+$33,717
D
2018-02-05
IDXXIdexx Laboratories Inc /deMcKeon Brian PEVP, CFOS - Sale+OE$181.37-6,60240,438-14%-$1,197,369
DM
2018-02-05
IDXXIdexx Laboratories Inc /deAyers Jonathan WCOB, Pres, CEOS - Sale+OE$179.28-36,0001,157,112-3%-$6,453,974
2018-02-07
VIVOMeridian Bioscience IncRice John McCune Jr.DirP - Purchase$14.75+1,0001,000New+$14,750
2018-02-02
NYMXNymox Pharmaceutical CorpRobinson James GeorgeDirP - Purchase$3.47+5,0003,090,5500%+$17,350
DM
2018-01-29
QDELQuidel Corp /de/Bryant Douglas CPres, CEOS - Sale+OE$46.95-36,000274,493-12%-$1,690,320
2018-01-29
NTLAIntellia Therapeutics, Inc.Caribou Biosciences, Inc.10%S - Sale$26.78-550,6453,994,355-12%-$14,746,273
M
2018-01-26
NEOGNeogen CorpBradley EdwardVP (Retired)S - Sale$60.29-11,7259,787-55%-$706,950
2018-01-26
NEOGNeogen CorpPapesh G BruceDirS - Sale$59.72-6,00018,196-25%-$358,320
2018-01-22
QDELQuidel Corp /de/Schuler Jack WDir, 10%S - Sale$48.50-12,0003,414,0530%-$582,031
D
2018-01-22
MYGNMyriad Genetics IncKing Gary A.EVP International OpsS - Sale+OE$39.67-34,445121,968-22%-$1,366,588
D
2018-01-22
MYGNMyriad Genetics IncMarsh Richard ME.VP, GCS - Sale+OE$40.25-37,654123,769-23%-$1,515,611
2018-01-18
NYMXNymox Pharmaceutical CorpRobinson James GeorgeDirP - Purchase$3.14+3,0003,085,5500%+$9,415
D
2018-01-18
MYGNMyriad Genetics IncMarsh Richard ME.VP, GCS - Sale+OE$38.25-40,000119,994-25%-$1,530,000

Real-time CSV? Options? Alerts? Contact us!
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top